“EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric Glycopeptide Use in Neutropenic Fever”. Mediterranean Journal of Hematology and Infectious Diseases 14, no. 1 (April 28, 2022): e2022039. Accessed June 5, 2026. https://www.mjhid.org/mjhid/article/view/4942.